Evaluating the federal role in financing health-related research

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 23, 1996, Pages 12717-12724

  Garber, Alan M ^a,b,c   Romer, Paul M ^c,d,e  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d STANFORD UNIVERSITY   (United States)

^e CANADIAN INSTITUTE FOR ADVANCED RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; MEDICAL RESEARCH; PRIORITY JOURNAL; TECHNOLOGY;

EID: 0029803912     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.23.12717     Document Type: Article

References (15)

1. Phelps, E. S. (1973) in Economic Justice, ed. Phelps, E. S. (Penguin Books, Baltimore), pp. 9-31.
2. Mishan, E. J. (1988) Cost-Benefit Analysis (Unwin Hyman, London).
3. Cornes, R. & Sandler, T. (1986) The Theory of Externalities, Public Goods, and Club Goods (Cambridge Univ. Press, Cambridge, U.K.).
4. Romer, P. (1993) Brookings Pap. Econ. Act. Microecon. 2, 345-390.
5. Pauly, M. V. (1968) Am. Econ. Rev. 58, 531-536.
6. Steering Committee of the Physicians' Health Study Research Group (1989) N. Engl. J. Med. 321, 129-135.
7. Gold, M. R., Siegel, J. E., Russell, L. B. & Weinstein, M. C., eds. (1996) Cost-Effectiveness in Health and Medicine (Oxford Univ. Press, New York).
8. Fuchs, V. R. & Garber, A. M. (1990) N. Engl. J. Med. 323, 673-677.
9. Feldstein, M. S. & Feenberg, D. (1996) in Tax Policy and the Economy, ed. Poterba, J. (MIT Press, Cambridge, MA), Vol. 10.
10. Rosenberg, N. (1994) in Economics of Technology, ed. Granstrand, O. (North-Holland, New York), pp. 323-337.
11. Antiplatelet Trialist Collaboration ( 1994) Br. Med. J. 308, 91-106.
12. Yusuf, S., Peto, R., Lewis, J., Collins, R. & Sleight, P. (1985) Prog. Cardiovasc. Dis. 27, 336-371.
13. Beta-Blocker Heart Attack Trial Research Group (1982) J. Am. Med. Assoc. 247, 1707-1714.
14. Garber, A. M., Clarke, A. E., Goldman, D. P. & Gluck, M. E. (1992) Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (U. S. Office of Technology Assessment, Washington, DC).
15. Beutler, E. & Garber, A. M. (1994) PharmacoEconomics 5, 453-459.